Questions about Hepatitis
Is there an increase in pediatric hepatitis of unknown cause in the US?
Recent reports indicate there was no increase in pediatric hepatitis of unknown cause or adenovirus trends in US children compared to pre-pandemic levels.
Full answer →What causes severe hepatitis in children with adenovirus infection in Alabama?
Severe hepatitis in children with adenovirus in Alabama is linked to specific enteric serotypes like 41, which cause intense liver inflammation and immune reactions, though the virus's exact role as the sole cause remains unclear.
Full answer →Has the US analysis found a common cause for acute hepatitis in kids?
US analysis has not found a single common cause for acute hepatitis in children, though some cases are linked to adenovirus while others remain unknown.
Full answer →Do adenovirus stool testing results show higher levels than pre-pandemic times?
No, adenovirus stool testing results have not shown higher levels than pre-pandemic times, according to US surveillance data.
Full answer →Is there an increase in pediatric hepatitis of unknown cause in the US?
No, US surveillance data through 2022 found no increase in pediatric hepatitis of unknown cause or adenovirus trends compared to pre-pandemic levels.
Full answer →Can adenovirus infection cause severe hepatitis in children?
Adenovirus infection has been found in children with severe acute hepatitis, but its exact role as the cause is still unclear to doctors.
Full answer →All Hepatitis Articles
- Evaluating the Impact of Digital Health Interventions on Chronic Disease Self-Care Outcomes
- Epigallocatechin-3-gallate shows positive therapeutic effects on various digestive system diseases in animal models
- HLA-B*57:01-guided abacavir prescribing is the clearest preventive paradigm from HLA associations
- PEG-IFN plus novel agents may boost functional cure in chronic hepatitis B
- Chronic HCV infection drives T cell dysfunction, regulatory T cell accumulation, and metabolic defects that persist after viral clearance
- 1 in 6 dromedary camels in Africa carries Rift Valley Fever antibodies
- One in six blood donors in Cameroon carries Plasmodium infection, meta-analysis finds
- Review of antiviral and immunotherapeutic strategies for chronic hepatitis B
- Meta-analysis identifies genetic variants linked to HBV susceptibility and HCC risk
- HEV 239 vaccine induces durable humoral and cellular immunity in Bangladeshi women
- Systematic review and meta-analysis of biopsy-guided versus clinically guided withdrawal in autoimmune hepatitis
- Pegylated interferon alpha associated with HBsAg clearance in postpartum women with chronic HBV infection
- Absence of antiviral therapy and multiple chemotherapeutic agents increase HBV reactivation risk after TACE
- Hepatic steatosis prevalence and impact in autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis
- Narrative review on ICIs in patients with viral infections and solid tumors
- HBV-positive status linked to higher surgical conversion in unresectable HCC receiving triple therapy
- Integrative review of Epimedium flavonoids in hepatitis and cirrhosis shows preclinical promise but lacks clinical validation
- Meta-analysis of 55 studies assesses HCV prevalence trends across Eastern Mediterranean Region populations
- Randomized trial shows ribavirin increases mutational load and specific transition signatures in HCV
- Narrative review synthesizes evidence on NAFLD, NASH, and viral hepatitis management without reported trial data
- Review of liver disease immunomodulation strategies notes precision over broad suppression
- Meta-analysis of 9 studies estimates HCV seroprevalence of 3.63% among African refugees and displaced persons
- Infliximab in IVIG-resistant Kawasaki disease with cholestatic hepatitis: case report
- Meta-analysis finds high prevalence of zoonotic diseases in African pastoralist livestock systems
- Peg-IFN-alpha treatment in HBeAg-negative chronic hepatitis B yields virological and serological responses
- Meta-analysis of 50 studies shows indeterminate chronic hepatitis B affects 39% of patients with elevated HCC risk
- Hepatitis E vaccine linked to elevated spontaneous abortion risk when given 31-60 days before pregnancy
- Machine learning models predict SVR in comorbid HCV patients treated with sofosbuvir, daclatasvir, and ribavirin in Pakistan
- Phase 2 trial of JNJ-73763989-based regimen shows no HBsAg seroclearance at primary endpoint in HBeAg-positive CHB
- Pegylated interferon-alpha toxicity mechanisms and management in chronic hepatitis B patients
- Baseline differences observed in HBV-TB versus simple HBV patients receiving anti-tuberculosis treatment
- Hospitalized malignant neoplasm patients show high comorbidity burden and distinct disease patterns across 163 Chinese hospitals
- Thymosin alpha1 added to standard therapy improved 90-day transplant-free survival in 73 patients with HBV-related acute-on-chronic liver failure
- Return to drinking occurs in 22% of alcohol-associated hepatitis patients within 90 days of recovery
- Hepatic steatosis compromises APRI and FIB-4 accuracy for staging fibrosis in chronic hepatitis B patients
- Global acute hepatitis C incidence declined overall but increased after 2015, analysis shows
- Meta-analysis finds 4% HBV transmission risk in kidney transplants from active HBV donors
- Hepatitis A infection reports increased 294% in the United States during 2016-2018
- CDC issues updated Hepatitis A immunization recommendations for United States population
- Updated guidance for hepatitis C virus exposure and acute infection in healthcare personnel
- Namibia reports first nationwide hepatitis E outbreak concentrated in informal settlements
- Hepatitis C cases increasing dramatically in US population, especially among younger adults
- CDC Recommends Universal Hepatitis C Screening for Adults and All Pregnant Women
- Surveillance report tracks drinking water-associated hepatitis A outbreaks from 1971 to 2017
- Hepatitis A outbreak cases reported across 26 states in observational data
- National trends show rising Hepatitis C and opioid use disorder rates in pregnant women at delivery
- Molecular testing used during hepatitis A outbreak investigation in Los Angeles County
- NHANES data show hepatitis B infection prevalence in US adults by race and origin
- Case report links alkaline bottled water to acute nonviral hepatitis in children
- Report describes donor-derived hepatitis B virus infections after liver transplantation
- WHO European Region progress toward hepatitis B control assessed from 2016 to 2019
- Case series describes children with severe hepatitis and adenovirus infection in Alabama
- Report finds no increase in pediatric hepatitis of unknown cause or adenovirus trends in US children
- Preliminary US analysis finds no common exposures in children with hepatitis of unknown cause
- Updated PHS guidelines recommend HIV, HBV, and HCV testing for pediatric transplant candidates under 12
- Hepatitis C treatment patterns examined in insured US adults
- Hepatitis A outbreak reported in the United States, details on scope and response not provided
- Report describes hepatitis A outbreak-related deaths in the United States
- CDC issues hepatitis C testing recommendations for perinatally exposed infants and children
- CDC issues new guidance for completing hepatitis C virus testing
- Updated recommendation supports universal hepatitis B vaccination for US adults aged 19-59 years
- Field report notes increased hepatitis A virus concentrations in Los Angeles County wastewater during outbreak
- Vaccination efforts target elimination of mother-to-child hepatitis B transmission in the Americas
- Case report associates acute hepatitis B infection with shared glucometer use in nursing home
- 8-week glecaprevir/pibrentasvir shows 96.2% SVR12 in acute HCV treatment-naïve adults
- HCV treatment with direct-acting antivirals linked to reduced alcohol use in people who inject drugs
- HBV RNA positivity at nucleoside analogue discontinuation linked to higher relapse risk in chronic hepatitis B
- Phase IIb trial of HH-003 injection for chronic HDV infection completes enrollment of 101 patients